PPARGC1A and polycystic ovary syndrome: Combined with our finding that PGC-1α was negatively correlated with miR-222-3p in PCOS patients, it could be inferred that miR-222-3p might play a regulatory role in glucose and lipid metabolism in PCOS patients by targeting PGC-1α.